Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

23
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
23
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

31
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
31
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

21
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
21
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

32
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
32
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

28
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
28
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

35
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
35

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Transformer-based models for predicting cardiovascular risk in Chinese adults: development and validation.

European heart journal·2026
Same author

Reporting Interest-Holder Engagement in Practice Guidelines: The RIGHT-MuSE Checklist.

Annals of internal medicine·2026
Same author

Single-Cell Transcriptome-Wide Mendelian Randomization and Colocalization Uncover Potential Immunocytes-Related Therapeutic Targets for Obesity.

Journal of cellular and molecular medicine·2026
Same author

Age-specific effects of hemoglobin A1c, blood pressure, and cholesterol levels on incident cardiovascular diseases among adults with diabetes in China: a 10-year prospective cohort study.

Life metabolism·2026
Same author

Association Between Socioeconomic Status and the Prevalence of Metabolic Diseases: A Nationwide Cross-Sectional Study in China.

Journal of diabetes·2026
Same author

Systematic Survey of Guidelines With Recommendations Related to Concordant Multimorbidity: Diabetes, Coronary Heart Disease and Stroke as an Example.

Journal of evaluation in clinical practice·2026

関連する実験動画

Updated: Sep 10, 2025

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective
06:14

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Published on: January 12, 2024

2.0K

中国における高尿血症と痛風の管理に関するガイドラインの2024年更新版 第2部:共通併発症の患者に対する勧告

Changgui Li1, Mingshu Sun2, Zhen Liu3

  • 1Department of Endocrinology, Xiang'an Hospital of Xiamen University, Xiamen, Fujian, China.

International journal of rheumatic diseases
|August 25, 2025
PubMed
まとめ

この更新されたガイドラインは,慢性腎臓病 (CKD) や心血管疾患 (CVD) などの一般的な併発性疾患を有する患者の痛風管理のための勧告を提供します. 厳格な血清尿酸目標と,最適な患者ケアのための抗炎症治療を優先する.

キーワード:
併発症痛風ガイドラインハイパーウリケミアマネジメント

さらに関連する動画

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

312
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

371

関連する実験動画

Last Updated: Sep 10, 2025

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective
06:14

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Published on: January 12, 2024

2.0K
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

312
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

371

科学分野:

  • リウマトロジ
  • 腎臓科
  • 心臓病科
  • 内分泌学
  • 胃腸内科

背景:

  • 併発性疾患の患者では,痛風の管理は複雑である.
  • 既存のガイドラインは,これらの特定の患者集団に対応するために更新する必要があります.

研究 の 目的:

  • 慢性腎臓病 (CKD),心血管疾患 (CVD),糖尿病,関節炎 (OA),胃腸疾患の患者における痛風管理のための包括的な,根拠に基づいた勧告を提供すること.

主な方法:

  • 複数の分野からなる 専門家パネルが開発したものです
  • PICO,体系的な文献レビュー,GRADE,デルフィー投票,専門家コンセンサスを利用しました.
  • 7つの臨床問題と26のエビデンスに基づいた勧告を扱った.

主要な成果:

  • 厳格な血清尿酸目標値を推奨し,特にCKDステージ ≥3,慢性痛風性関節炎,OAの患者に推奨する.
  • 心臓病や糖尿病の患者には全身性グルココルチコイドより 内トリアムシノロンを推奨する.
  • CKD,胃腸疾患,OAに対する特定の抗炎症治療を優先します.
  • インタールイキン-1阻害剤や選択性尿酸輸送阻害剤などの新興治療法を導入する.

結論:

  • 更新されたガイドラインは,併発症患者の痛風管理に患者中心のアプローチを提供します.
  • 多分野間の協力と新しい証拠により 推奨の最適化が進んでいます